Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II Trial of Inactivated EV71 Vaccine in Children and Infants
NCT01399853Phase 2Completed
- Sponsor
- Jiangsu Provincial Center for Disease Control and Prevention
- Start
- Jul 2011
- Primary completion
- Nov 2011
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of inactivated EV71 vaccine in HIV-associated central nervous system involvement (HAND) (10 arms), sponsored by Jiangsu Provincial Center for Disease Control and Prevention. Primary endpoints: Geometric Mean Titer of anti-EV71 antibodies and Frequency of systemic and local adverse reactions. Started Jul 2011; status: completed.
02
Drugs
inactivated EV71 vaccine
03
Conditions
HIV-associated central nervous system involvement (HAND)
Beyond the preview
Go deeper on NCT01399853.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01399853.